Median Technologies will make three presentations at the annual conference of the RSNA (Radiological Society of North America) to be held from November 27 to December 1 in Chicago, USA
• Presentation at AI Showcase Theater: “Enabling Lung Cancer Screening with iBiopsy® AI-based Software as Medical Device”
• Scientific presentation: ”Development of an AI/ML Tech Based Pulmonary Nodule Malignancy Prediction Model: Application to Indeterminate Pulmonary Nodules and Early-Stage Cancers”
• Scientific poster (virtual presentation): “Discordance rates on primary tumor assessment between Blinded Independent Central Review (BICR) readers in advanced or metastatic esophageal cancer applying RECIST 1.1 criteria”
• The Median teams will be on stand 4849 (AI showcase) to present the latest developments of iBiopsy® as well as the iCRO offer
Sophia Antipolis, France – Median Technologies (ALMDT) announces today that the company will participate in the world’s largest medical imaging conference, the RSNA (Radiological Society of North America) Annual Conference to be held in Chicago, USA. United, from November 27 to December 1, 2022.
The company will make an industrial presentation and two scientific presentations.